author-photo

Alvin Milner

Sarah Cannon Research Institute

1

Papers

5

Citations

Citation Trend

Filter By

Papers (1) Sort By

Journal Conference Others

Randomized phase II study of sunitinib + CXCR4 inhibitor LY2510924 versus sunitinib alone in first-line treatment of patients with metastatic renal cell carcinoma.

2015 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (5)